कृपया अन्य खोज का प्रयास करें
Jubilant Pharmova Limited operates as an integrated pharmaceutical and life sciences company in India, the Americas, Europe, and internationally. It operates through six segments: Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, Generics, Contract Research Development & Manufacturing Organisation (CRDMO), and Proprietary Novel Drugs. The Radiopharma segment offers radiopharmaceuticals products, which are used in the diagnosis and treatment of various diseases, including pulmonary embolism, cancer, coronary artery disease, and others. The Allergy Immunotherapy segment provides specialised diagnostic devices for skin testing, as well as venom immunotherapy products. The CDMO Sterile Injectables segment offers contract manufacturing services for sterile fill and finish injectables, liquids, ointments, creams, and ampoules. The Generics segment engages in the development, manufacturing, distribution, sale, and marketing of solid dosage formulations for therapeutic areas comprising cardiovascular system, central nervous system, gastrointestinal, and multispecialty. The CRDMO segment offers drug discovery and development services and active pharmaceutical ingredients. The Proprietary Novel Drugs segment develops therapies in the areas of oncology and auto-immune diseases. The company was formerly known as Jubilant Life Sciences Limited and changed its name to Jubilant Pharmova Limited in February 2021. Jubilant Pharmova Limited was incorporated in 1978 and is based in Noida, India.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Shyam Sunder Bhartia | 69 | 1978 | Chairman |
Hari Shanker Bhartia | 67 | 1982 | Co-Chairman |
Arvind Chokhany | 51 | 2021 | Group CFO & Whole-Time Director |
Arjun Shanker Bhartia | 36 | 2017 | Joint MD & Director |
Priyavrat Bhartia | 47 | 2017 | MD & Director |
Jinang Pratap Parekh | 42 | 2023 | Whole-Time Director |
Sushil Kumar Roongta | 74 | 2017 | Independent Non-Executive Director |
Arun Seth | 73 | 2018 | Independent Non-Executive Director |
Vivek Mehra | 67 | 2017 | Independent Non-Executive Director |
Shirish Gundopant Belapure | 71 | 2023 | Additional Independent Non-Executive Director |
Shivpriya Nanda | 60 | 2024 | Independent Director |
Harsh Mahajan | 65 | 2024 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है